A carregar...

Menogaril, an Anthracycline Compound with a Novel Mechanism of Action: Cellular Pharmacology

Menogaril, an anthracycline compound possessing a significant antitumor activity after both po and iv administration, has been introduced into clinical trials. However, its mechanism of action has not been clarified yet. This study revealed that its cytotoxicity correlated very well with the inhibit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Jpn J Cancer Res
Main Authors: Wierzba, Konstanty, Sugimoto, Yoshikazu, Matsuo, Ken‐ichi, Toko, Toshiyuki, Takeda, Setsuo, Yamada, Yuji, Tsukagoshi, Shigeru
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 1990
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918082/
https://ncbi.nlm.nih.gov/pubmed/2144516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1990.tb02654.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!